Crohn’s is an aggressive inflammatory bowel disease driven by interactions of unknown relative significance between the immune system, the microbiome, and the intervening intestinal epithelial barrier. Histopathology analyses and genome-wide association studies (GWAS) have provided renewed focus on the role of the mucosal barrier in this disease.